Atlas Trials

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder

Clinical trial NCT02670538 · COMPLETED

Trial details

NCT number
NCT02670538
Sponsor
Forest Laboratories
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar DisorderDepression
Start date
2016-03-31
Primary completion
2018-01-18
Enrollment
493

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.